Cytomegalovirus Infections in Non-Immunocompromised and Immunocompromised Patients in the Intensive Care Unit

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 11, Iss. 4, 2011-08 ,pp. : 354-364

Bentham Science Publishers

Access to resources Recommend Favorite

Valganciclovir: oral prevention and treatment of cytomegalovirus in the immunocompromised host

By Freeman Richard B  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 9, 2004-09 ,pp. : 2007-2016

Informa Healthcare

Access to resources Recommend Favorite

Oral valganciclovir: a new option for treatment of cytomegalovirus infection and disease in immunocompromised hosts

By Reusser Pierre  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 9, 2001-09 ,pp. : 1745-1753

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Invasive Candidiasis in Immunocompromised Pediatric Patients

By Fisher Brian T.   Zaoutis Theoklis E.  

Pediatric Drugs, Vol. 10, Iss. 5, 2008-01 ,pp. : 281-298

Adis International

Access to resources Recommend Favorite

Cytomegalovirus Infection in Pediatric Immunocompromised Hosts

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 11, Iss. 5, 2011-10 ,pp. : 437-448

Bentham Science Publishers

Access to resources Recommend Favorite